IST:BIOEN Statistics

Total Valuation

IST:BIOEN has a market cap or net worth of TRY 10.50 billion. The enterprise value is 14.80 billion.

Market Cap	10.50B
Enterprise Value	14.80B

Important Dates

The last earnings date was Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

IST:BIOEN has 500.00 million shares outstanding. The number of shares has decreased by -0.17% in one year.

Current Share Class	500.00M
Shares Outstanding	500.00M
Shares Change (YoY)	-0.17%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	20.78%
Float	227.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.20
PB Ratio	2.56
P/TBV Ratio	2.91
P/FCF Ratio	26.47
P/OCF Ratio	10.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-15.81
EV / Sales	5.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	37.31

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of 1.06.

Current Ratio	0.57
Quick Ratio	0.18
Debt / Equity	1.06
Debt / EBITDA	20.20
Debt / FCF	11.00
Interest Coverage	-1.04

Financial Efficiency

Return on equity (ROE) is -23.93% and return on invested capital (ROIC) is -3.22%.

Return on Equity (ROE)	-23.93%
Return on Assets (ROA)	-2.97%
Return on Invested Capital (ROIC)	-3.22%
Return on Capital Employed (ROCE)	-5.58%
Revenue Per Employee	3.48M
Profits Per Employee	-1.31M
Employee Count	717
Asset Turnover	0.29
Inventory Turnover	6.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.08% in the last 52 weeks. The beta is -0.01, so IST:BIOEN's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	+18.08%
50-Day Moving Average	19.46
200-Day Moving Average	17.83
Relative Strength Index (RSI)	45.33
Average Volume (20 Days)	4,239,251

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IST:BIOEN had revenue of TRY 2.50 billion and -936.02 million in losses. Loss per share was -1.87.

Revenue	2.50B
Gross Profit	32.29M
Operating Income	-407.98M
Pretax Income	-375.04M
Net Income	-936.02M
EBITDA	116.28M
EBIT	-407.98M
Loss Per Share	-1.87

Full Income Statement

Balance Sheet

The company has 63.14 million in cash and 4.36 billion in debt, giving a net cash position of -4.30 billion or -8.60 per share.

Cash & Cash Equivalents	63.14M
Total Debt	4.36B
Net Cash	-4.30B
Net Cash Per Share	-8.60
Equity (Book Value)	4.11B
Book Value Per Share	8.21
Working Capital	-808.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -629.71 million, giving a free cash flow of 396.67 million.

Operating Cash Flow	1.03B
Capital Expenditures	-629.71M
Free Cash Flow	396.67M
FCF Per Share	0.79

Full Cash Flow Statement

Margins

Gross margin is 1.29%, with operating and profit margins of -16.34% and -37.48%.

Gross Margin	1.29%
Operating Margin	-16.34%
Pretax Margin	-15.02%
Profit Margin	-37.48%
EBITDA Margin	4.66%
EBIT Margin	-16.34%
FCF Margin	15.88%

Dividends & Yields

IST:BIOEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.17%
Shareholder Yield	n/a
Earnings Yield	-8.91%
FCF Yield	3.78%

Stock Splits

The last stock split was on November 24, 2021. It was a forward split with a ratio of 3.3333333.

Last Split Date	Nov 24, 2021
Split Type	Forward
Split Ratio	3.3333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a